Log in

Exploring the relationship between fall risk-increasing drugs and fall-related fractures

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background

Hospital admissions due to fall-related fractures are a major problem in the aging population. Several risk factors have been identified, including drug use. Most studies often retrieved prescription-only drugs from national databases. These are associated with some limitations as they do not always reliably reproduce the complete patient’s active drug list.

Objective

To evaluate the association between the number of FRIDs intake identified by a standardised medication reconciliation process and a fall-related fracture leading to a hospital admission in older adults.

Setting

The first cohort has been recruited from one traumatology ward of a tertiary teaching hospital in Belgium and the second cohort has been recruited from 11 community pharmacies in Belgium.

Method

A prospective study with two individually matched cohorts was performed. Adult patients (≥75 years) admitted with an injury due to a fall were included in the first cohort (faller group). The second cohort consisted of patients who did not suffer from a fall within the last 6 months (non-faller group). Matching was performed for age, gender, place of residence and use of a walking aid. In both groups, clinical pharmacists and undergraduate pharmacy students obtained the medication history, using a standardised approach. A list of drugs considered to increase the risk of falling was created. It included cardiovascular drugs and drugs acting on the nervous system. A linear mixed model was used to compare the number of fall risk-increasing drugs between fallers and non-fallers.

Main outcome measure

The number of fall risk-increasing drugs in a faller versus a non-faller group.

Results

Sixty-one patients were matched with 121 non-fallers. Patients received on average 3.1 ± 2.1 and 3.2 ± 1.8 fall risk-increasing drugs in the faller and in the non-faller group, respectively. The mean number of fall risk-increasing drugs was comparable in both groups (p = 0.844), even after adjusting for alcohol consumption, fear of falling, vision and foot problems (p = 0.721).

Conclusion

In a sample of hospitalised patients admitted for a fall-related injury, no significant difference in the number of fall risk-increasing drugs versus that of an outpatient group of non-fallers was found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rubenstein LZ, Josephson KR. Falls and their prevention in elderly people: what does the evidence show? Med Clin North Am. 2006;90:807–24.

    Article  PubMed  Google Scholar 

  2. Pohl P, Nordin E, Lundquist A, Bergström U, Lundin-Olsson L. Community-dwelling older people with an injurious fall are likely to sustain new injurious falls within 5 years—a prospective long-term follow-up study. BMC Geriatr. 2014;14:120. doi:10.1186/1471-2318-14-120.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karlsson MK, Vonschewelov T, Karlsson C, Cöster M, Rosengen BE. Prevention of falls in the elderly: a review. Scand J Public Health. 2013;41:442–54.

    Article  PubMed  Google Scholar 

  4. Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29:359–76.

    Article  CAS  PubMed  Google Scholar 

  5. Campbell AJ. Drug treatment as a cause of falls in old age. A review of the offending agents. Drugs Aging. 1991;1:289–302.

    Article  CAS  PubMed  Google Scholar 

  6. Bulat T, Castle SC, Rutledge M, Quigley P. Clinical practice algorithms: medication management to reduce fall risk in the elderly—part 3, benzodiazepines, cardiovascular agents, and antidepressants. J Am Acad Nurse Pract. 2008;20:55–62.

    Article  PubMed  Google Scholar 

  7. Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174:890–8.

    Article  PubMed  Google Scholar 

  8. Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9:CD007146. doi:10.1002/14651858.CD007146.pub3.

    PubMed  Google Scholar 

  9. Cameron ID, Gillespie LD, Robertson MC, Murray GR, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev. 2012;12:CD005465. doi:10.1002/14651858.CD005465.pub3.

    PubMed  Google Scholar 

  10. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47:30–9.

    Article  CAS  PubMed  Google Scholar 

  11. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40–50.

    Article  CAS  PubMed  Google Scholar 

  12. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–60.

    Article  PubMed  Google Scholar 

  13. Gribbin J, Hubbard R, Gladman JR, Smith C, Lewis S. Risk of falls associated with antihypertensive medication: population-based case-control study. Age Ageing. 2010;39:592–7.

    Article  PubMed  Google Scholar 

  14. Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S. Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf. 2011;20:879–84.

    Article  PubMed  Google Scholar 

  15. Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. 2011;10:CD005185. doi:10.1002/14651858.CD005185.pub2.

    PubMed  Google Scholar 

  16. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172:1739–44.

    Article  PubMed  Google Scholar 

  17. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int. 2013;24:2649–57.

    Article  CAS  PubMed  Google Scholar 

  18. Lapane KL, Yang S, Brown MJ, Jawahar R, Pagliasotti C, Rajpathak S. Sulfonylureas and risk of falls and fractures: a systematic review. Drugs Aging. 2013;30:527–47.

    Article  CAS  PubMed  Google Scholar 

  19. Bloch F, Thibaud M, Tournoux-Facon C, Brèque C, Rigaud AS, Dugué B, et al. Estimation of the risk factors for falls in the elderly: can meta-analysis provide a valid answer? Geriatr Gerontol Int. 2013;13:250–63.

    Article  PubMed  Google Scholar 

  20. Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174:588–95.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Milos V, Bondesson A, Magnusson M, Jakobsson U, Westerlund T, Midlöv P. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14:40. doi:10.1186/1471-2318-14-40.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med. 2006;260:350–62.

    Article  CAS  PubMed  Google Scholar 

  23. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006;24:581–9.

    Article  CAS  PubMed  Google Scholar 

  24. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005;173:510–5.

    Article  PubMed  PubMed Central  Google Scholar 

  25. De Winter S, Spriet I, Indevuyst C, Vanbrabant P, Desruelles D, Sabbe M, et al. Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Qual Saf Health Care. 2010;19:371–5.

    PubMed  Google Scholar 

  26. Etchells E, Koo M, Daneman N, McDonald A, Baker M, Matlow A, et al. Comparative economic analyses of patient safety improvement strategies in acute care: a systematic review. BMJ Qual Saf. 2012;21:448–56.

    Article  PubMed  Google Scholar 

  27. van den Bemt PM, van der Schrieck-de Loos EM, van der Linden C, Theeuwes AM, Pol AG, Dutch CBO WHO High 5 s Study Group. Effect of medication reconciliation on unintentional medication discrepancies in acute hospital admissions of elderly adults: a multicenter study. J Am Geriatr Soc. 2013;61:1262–8.

    Article  PubMed  Google Scholar 

  28. World Health Organisation (WHO) (2013) Guidelines for ATC classification and DDD assignment (document on the internet). Oslo: WHO collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf.

  29. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    Article  CAS  PubMed  Google Scholar 

  30. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:404–15.

    Article  PubMed  Google Scholar 

  31. (2011) Expertisecentrum Val-en fractuurpreventie Vlaanderen. Draaiboek zorgpad valpreventie (document on the internet). Expertisecentrum Val-en fractuurpreventie Vlaanderen. http://www.valpreventie.be/Portals/Valpreventie/Documenten/thuis/EVV_Draaiboek_zorgpad_valpreventie.pdf.

  32. Lindquist LA, Gleason KM, McDaniel MR, Doeksen A, Liss D. Teaching medication reconciliation through simulation: a patient safety initiative for second year medical students. J Gen Intern Med. 2008;23:998–1001.

    Article  PubMed  PubMed Central  Google Scholar 

  33. French DD, Campbell R, Spehar A, Cunningham F, Bulat T, Luther SL. Drugs and falls in community-dwelling older people: a national veterans study. Clin Ther. 2006;28:619–30.

    Article  PubMed  Google Scholar 

  34. Lamis RL, Kramer JS, Hale LS, Zackula RE, Berg GM. Fall risk associated with inpatient medications. Am J Health Syst Pharm. 2012;69:1888–94.

    Article  PubMed  Google Scholar 

  35. Kelsey J, Berry SD, Procter-Gray E, Quach L, Nguyen US, Li W, et al. Indoor and outdoor falls in older adults are different: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston Study. J Am Geriatr Soc. 2010;58:2135–41.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Giladi AM, Shauver MJ, Ho A, Zhong L, Kim HM, Chung KC. Variation in the incidence of distal radius fractures in the U.S. elderly as related to slippery weather conditions. Plast Reconstr Surg. 2014;133:321–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Echt MA, Samelson EJ, Hannan MT, Dufour AB, Berry SD. Psychotropic drug initiation or increased dosage and the acute risk of falls: a prospective cohort study of nursing home residents. BMC Geriatr. 2013;13:19. doi:10.1186/1471-2318-13-9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med. 2013;173:754–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to express our special thanks to Prof. Dr. Apr. Gert Laekeman, Clinical Pharmacology and Pharmacotherapy, Dpt Pharmaceutical and Pharmacological Sciences, KU Leuven, for his contribution to this study, to keep this project on track in the community pharmacies and for carefully reading this manuscript. We would like to thank all the collaborating undergraduate pharmacy students and the community pharmacies. Finally, we also want to thank Annouschka Laenen, Leuven Biostatistics and Statistical Bioinformatics Centre, Dpt of Public Health and Primary Care, KU Leuven for the statistical assistance.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sabrina De Winter.

Ethics declarations

Conflicts of interest

None.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Winter, S., Vanwynsberghe, S., Foulon, V. et al. Exploring the relationship between fall risk-increasing drugs and fall-related fractures. Int J Clin Pharm 38, 243–251 (2016). https://doi.org/10.1007/s11096-015-0230-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-015-0230-0

Keywords

Navigation